Haemonetics GmbH, headquartered in Munich, is a 100% subsidiary of Haemonetics Corporation (Braintree, USA) and conducts the purchase, import and distribution of medical devices and accessories, in particular blood processing and blood management systems. In the fiscal year 2023/2024 the company reported revenues of TEUR 26,279 and organizes its business into the Hospital, Blood Center, Plasma and Software & Service segments. As of 31 March 2024 the company employed 41 staff members across sales, administration and technical/clinical service. The share capital amounts to EUR 1,032,809.60 and the company reported cash and cash equivalents of EUR 3,084,221.85 at the reporting date.
Kauf, Import und Vertrieb von medizinischen Geräten und Zubehörteilen jeglicher Art, insbesondere solcher, die von Haemonetics Corporation, Braintree, Massachusetts, USA hergestellt werden.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) München Local Court, HRB 65909 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| James D'Arecca | Geschäftsführer(in) | Allendale |
| Floriane Gallay | Geschäftsführer(in) | La Rippe |
| Roberto Narduzzi | Geschäftsführer(in) | Gilly |
| Nicolas Wattin | Geschäftsführer(in) | Saint-Sixt |
Source: German Commercial Register (Handelsregister) München Local Court, HRB 65909 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2025 | Rohergebnis€9.4M2 | €1,049,663 | €25,256,222 | — |
| 2024 | Rohergebnis€8.7M2 | €319,674 | €22,307,801 | — |
| 2023 | Rohergebnis€7M2 | €894,328 | €20,910,187 | — |
| 2022 | €21,658,652 | -€14,423 | €18,815,024 | — |
| 2021 | €22,921,012 | €1,363,802 | €19,812,503 | — |
| 2020 | €24,650,363 | -€307,555 | €17,468,571 | — |
| 2019 | €24,162,484 | -€203,280 | €16,441,596 | — |
| 2018 | Rohergebnis€6.7M2 | -€26,895 | €16,776,570 | — |
| 2017 | Rohergebnis€7.4M2 | -€24,051 | €15,564,385 | — |
| 2016 | Rohergebnis€7.5M2 | €577,840 | €15,292,667 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) München Local Court, HRB 65909 (as of 30 October 2026)
Thermo Fisher Diagnostics GmbH
Hennigsdorf · Großhandel mit medizinischen und orthopädischen Artikeln, Dental- und Laborbedarf
CooperVision GmbH
Darmstadt · Großhandel mit Foto- und optischen Erzeugnissen
Ordamed GmbH
Berlin · Einzelhandel mit sonstigen medizinischen und orthopädischen Artikeln
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €4,759,817 | 79.8% |
| Depreciation | €1,162,855 | 19.5% |
| Interest & Similar | €44,501 | 0.7% |
